• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黑色素瘤代谢:皮肤肿瘤学中的分子机制与治疗意义。

Melanoma Metabolism: Molecular Mechanisms and Therapeutic Implications in Cutaneous Oncology.

机构信息

Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.

Department of Dermatology, The Johns Hopkins Hospital, Baltimore, Maryland, USA.

出版信息

Cancer Med. 2024 Nov;13(21):e70386. doi: 10.1002/cam4.70386.

DOI:10.1002/cam4.70386
PMID:39494561
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11532834/
Abstract

BACKGROUND

Melanoma, a highly aggressive skin cancer, is characterized by rapid progression and a high metastatic potential, presenting significant challenges in clinical oncology. A critical aspect of melanoma biology is its metabolic reprogramming, which supports tumor growth, survival, and therapeutic resistance.

OBJECTIVE

This review aims to explore the key molecular mechanisms driving metabolic alterations in melanoma and their implications for developing therapeutic strategies.

METHODS

A Pubmed search was conducted to analyze literature discussing key mechanisms of the Warburg effect, mitochondrial dysfunction, enhanced lipid metabolism, epigenetic modifications, and the tumor microenvironment.

RESULTS

Metabolic reprogramming supports melanoma growth, proliferation, and survival. Understanding these complex metabolic dynamics provides valuable insights for developing targeted therapeutic strategies.

CONCLUSION

Potential therapeutic interventions aimed at disrupting melanoma metabolism highlight the promise of precision medicine in improving treatment outcomes in cutaneous oncology. By targeting metabolic vulnerabilities, novel treatment approaches could significantly enhance the clinical management and prognosis of melanoma.

摘要

背景

黑色素瘤是一种侵袭性很强的皮肤癌,其特点是进展迅速、转移潜能高,给临床肿瘤学带来了重大挑战。黑色素瘤生物学的一个关键方面是其代谢重编程,这支持了肿瘤的生长、存活和治疗抵抗。

目的

本综述旨在探讨驱动黑色素瘤代谢改变的关键分子机制及其对开发治疗策略的意义。

方法

通过 Pubmed 搜索,分析了讨论沃伯格效应、线粒体功能障碍、增强脂质代谢、表观遗传修饰和肿瘤微环境等关键机制的文献。

结果

代谢重编程支持黑色素瘤的生长、增殖和存活。了解这些复杂的代谢动态为开发靶向治疗策略提供了有价值的见解。

结论

旨在破坏黑色素瘤代谢的潜在治疗干预措施强调了精准医学在改善皮肤肿瘤学治疗结果方面的前景。通过靶向代谢脆弱性,新的治疗方法可以显著提高黑色素瘤的临床管理和预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/473a/11532834/823b31ae7b70/CAM4-13-e70386-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/473a/11532834/5a3b5f9d0b42/CAM4-13-e70386-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/473a/11532834/823b31ae7b70/CAM4-13-e70386-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/473a/11532834/5a3b5f9d0b42/CAM4-13-e70386-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/473a/11532834/823b31ae7b70/CAM4-13-e70386-g003.jpg

相似文献

1
Melanoma Metabolism: Molecular Mechanisms and Therapeutic Implications in Cutaneous Oncology.黑色素瘤代谢:皮肤肿瘤学中的分子机制与治疗意义。
Cancer Med. 2024 Nov;13(21):e70386. doi: 10.1002/cam4.70386.
2
Cancer stem cells, epigenetics, tumor microenvironment and future therapeutics in cutaneous malignant melanoma: a review.癌症干细胞、表观遗传学、肿瘤微环境与皮肤恶性黑色素瘤的未来治疗策略:综述
Future Oncol. 2020 Jul;16(21):1549-1567. doi: 10.2217/fon-2020-0151. Epub 2020 Jun 2.
3
Mitochondrial oxidative phosphorylation in cutaneous melanoma.皮肤黑色素瘤中的线粒体氧化磷酸化。
Br J Cancer. 2021 Jan;124(1):115-123. doi: 10.1038/s41416-020-01159-y. Epub 2020 Nov 18.
4
Therapeutic implications of the metabolic changes associated with BRAF inhibition in melanoma.与 BRAF 抑制相关的黑色素瘤代谢变化的治疗意义。
Cancer Treat Rev. 2024 Sep;129:102795. doi: 10.1016/j.ctrv.2024.102795. Epub 2024 Jun 28.
5
Melanoma Metabolism: Cell Survival and Resistance to Therapy.黑色素瘤代谢:细胞存活与治疗抵抗
Adv Exp Med Biol. 2020;1219:203-223. doi: 10.1007/978-3-030-34025-4_11.
6
Targeting metabolic reprogramming as a potential therapeutic strategy in melanoma.将代谢重编程作为黑色素瘤的一种潜在治疗策略。
Pharmacol Res. 2016 May;107:42-47. doi: 10.1016/j.phrs.2016.02.009. Epub 2016 Feb 26.
7
Targeting tumour metabolism in melanoma to enhance response to immune checkpoint inhibition: A balancing act.针对黑色素瘤肿瘤代谢以增强对免疫检查点抑制的反应:一种平衡行为。
Cancer Treat Rev. 2024 Sep;129:102802. doi: 10.1016/j.ctrv.2024.102802. Epub 2024 Jul 11.
8
Unraveling lipid metabolism reprogramming for overcoming drug resistance in melanoma.解析黑色素瘤耐药性相关的脂质代谢重编程。
Biochem Pharmacol. 2024 May;223:116122. doi: 10.1016/j.bcp.2024.116122. Epub 2024 Mar 10.
9
Increased inflammatory lipid metabolism and anaplerotic mitochondrial activation follow acquired resistance to vemurafenib in BRAF-mutant melanoma cells.在 BRAF 突变型黑色素瘤细胞中,获得性vemurafenib 耐药后炎症脂质代谢增加和补充性线粒体激活。
Br J Cancer. 2020 Jan;122(1):72-81. doi: 10.1038/s41416-019-0628-x. Epub 2019 Dec 10.
10
EZH2: an emerging role in melanoma biology and strategies for targeted therapy.EZH2:在黑色素瘤生物学中的新作用及靶向治疗策略
Pigment Cell Melanoma Res. 2015 Jan;28(1):21-30. doi: 10.1111/pcmr.12280. Epub 2014 Jun 27.

本文引用的文献

1
Pathogenic mitochondrial DNA mutations inhibit melanoma metastasis.致病性线粒体 DNA 突变抑制黑色素瘤转移。
Sci Adv. 2024 Nov;10(44):eadk8801. doi: 10.1126/sciadv.adk8801. Epub 2024 Nov 1.
2
Efficacy of axitinib in a US cohort of patients with programmed cell death protein 1-resistant mucosal melanoma.阿昔替尼在美国队列的程序性死亡蛋白 1 耐药黏膜黑色素瘤患者中的疗效。
Melanoma Res. 2024 Oct 1;34(5):450-456. doi: 10.1097/CMR.0000000000000988. Epub 2024 Jun 28.
3
A Multimodal Drug-Diet-Immunotherapy Combination Restrains Melanoma Progression and Metastasis.
多模态药物-饮食-免疫疗法联合抑制黑色素瘤的进展和转移。
Cancer Res. 2024 Jul 15;84(14):2333-2351. doi: 10.1158/0008-5472.CAN-23-1635.
4
Eating away cancer: the potential of diet and the microbiome for shaping immunotherapy outcome.饮食抗癌:饮食和微生物组对免疫疗法结果的影响。
Front Immunol. 2024 May 30;15:1409414. doi: 10.3389/fimmu.2024.1409414. eCollection 2024.
5
Unraveling lipid metabolism reprogramming for overcoming drug resistance in melanoma.解析黑色素瘤耐药性相关的脂质代谢重编程。
Biochem Pharmacol. 2024 May;223:116122. doi: 10.1016/j.bcp.2024.116122. Epub 2024 Mar 10.
6
A Potential "Anti-Warburg Effect" in Circulating Tumor Cell-mediated Metastatic Progression?循环肿瘤细胞介导的转移进展中存在潜在的“抗瓦伯格效应”?
Aging Dis. 2024 Jan 11;16(1):269-82. doi: 10.14336/AD.2023.1227.
7
Mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade response in melanoma.线粒体 DNA 突变驱动有氧糖酵解以增强黑色素瘤的检查点封锁反应。
Nat Cancer. 2024 Apr;5(4):659-672. doi: 10.1038/s43018-023-00721-w. Epub 2024 Jan 29.
8
The oncogenic role of SAMMSON lncRNA in tumorigenesis: A comprehensive review with especial focus on melanoma.SAMMSON lncRNA 在肿瘤发生中的致癌作用:全面综述,特别关注黑色素瘤。
J Cell Mol Med. 2023 Dec;27(24):3966-3973. doi: 10.1111/jcmm.17978. Epub 2023 Sep 29.
9
Oncogenic DNA methyltransferase 1 activates the PI3K/AKT/mTOR signalling by blocking the binding of HSPB8 and BAG3 in melanoma.致癌 DNA 甲基转移酶 1 通过阻断 HSPB8 和 BAG3 与黑色素瘤中 PI3K/AKT/mTOR 信号的结合来激活该信号。
Epigenetics. 2023 Dec;18(1):2239607. doi: 10.1080/15592294.2023.2239607.
10
Efficacy and safety of bevacizumab in patients with malignant melanoma: a systematic review and PRISMA-compliant meta-analysis of randomized controlled trials and non-comparative clinical studies.贝伐单抗治疗恶性黑色素瘤患者的疗效和安全性:一项随机对照试验和非对照临床研究的系统评价及符合PRISMA标准的荟萃分析
Front Pharmacol. 2023 Jul 13;14:1163805. doi: 10.3389/fphar.2023.1163805. eCollection 2023.